← Back to News•Source: Nikkei Asia
Travel Alerts
Japan startup eyes clinical trials for stem cell-based diabetes treatment
JP
By The Japanist TeamOrizuru Therapeutics seeks breakthrough to reduce insulin doses for Type 1 patients
Orizuru Therapeutics seeks breakthrough to reduce insulin doses for Type 1 patients
Original source:Nikkei Asia ↗
More Japan News
Travel Alerts
Singapore Aims to Be Gold Hub
Singapore is partnering with JPMorgan and UBS to establish itself as a major gold hub. The city-state also plans to offer vaulting services for foreign central banks.
Read article
Travel Alerts
Iran war shows Japan needs Alaskan oil: ex-vice foreign minister
Tokyo shifted US toward tougher line on China in Taiwan Strait, Mori says
Read article
Travel Alerts
Analysis: Xi Jinping finds himself in a Japan-US dilemma
The Chinese leader wants to attack Sanae Takaichi but not Donald Trump
Read article